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Zika vírus, um Flavivirus isolado pela primeira vez NA África, se espalhou para muitos países do mundo, in-
cluindo o Brasil. Neste país, sete meses após a Copa do Mundo de futebol, foi registrada a ocorrência de uma 
epidemia, posteriormente associada a casos de microcefalia e síndrome de Guillain-Barre. O vírus é transmitido 
por mosquitos do gênero Aedes, frequenctemente aapós uma picada de um vetor infectado. A doença febril é 
auto-limitada e não há nenhum tratamento específico. Poucos meses após este surto no Brasil, as autoridades 
reconheceram a associação entre o Zika vírus e a ocorrência de síndrome de Guillain-Barre e microcefalia em 
recém-nascidos, o que corresponde a malformações cerebrais fetais ou lesões cerebrais. Esta descoberta é 
um alerta mundial para o fortalecimento de medidas preventivas, restrito a prevenção de picadas de insetos 
e cuidado com o meio ambiente.
Zika vírus, a Flavivirus first isolated in Africa, has spread to many countries worldwide including Brazil. In this 
country, seven months after the World Football Cup, the occurrence of an epidemic was recorded, subsequen-
tly associated to cases of microcephaly and Guillain-Barre syndrome. The virus is transmitted by mosquitoes of 
the Aedes genus, often following a bite from an infected vector. The febrile disease is self-limited and there is 
no specific treatment. Few months after this outbreak in Brazil, the authorities acknowledged the association 
between the Zika virus and the occurrence of Guillain-Barre syndrome and microcephaly in newborns, corres-
ponding to fetal cerebral malformation or brain lesions. This finding is a worldwide alert for the strengthening 
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INTRODUCTION
In the past three years, several emergent dis-
eases - including vector-transmitted diseases, such 
as arboviruses - were noticed as increasing around 
the world, especially because of climate changes 
as well as globalization of travel and trade. These 
diseases include those caused by the Flaviviridae 
Family, which comprises over 70 different members and 
includes the Dengue virus, the Japanese Encephalitis 
virus and the Yellow Fever virus.1-3 There are serologi-
cal evidences that the Zika virus first isolated in Africa, 
has spread to Asia since 1966.3 Few human cases were 
reported until 2007, when a Zika fever epidemic took 
place in Micronesia. Some major outbreaks were then 
described in Thailand in 2012-2014. In that country, it is 
now considered widespread.4 In December 2013, there 
was a Zika virus outbreak in the French Polynesia and the 
New Caledonia, when 396 laboratory-confirmed cases 
occurred and an estimated 29,000 people sought med-
ical care for suspected Zika illness. In that outbreak, 70 
cases presented neurological or auto-immune complica-
tions.5 In 2013, the Zika virus had its complete coding 
sequenced.6 However, at that time, Zika virus was not 
described as a particular problem in Brazil.
According to the World Tourism Organization, over 
1,1 billion tourists travelled abroad in 2014. In Brazil, there 
were several international events with the arrival of large 
numbers of people from various parts of the world.3,7 In 
February 2015, seven months after the football world cup 
was held in the country, the Ministry of Health in Brazil 
registered the occurrence of a new viral febrile syndrome, 
affecting mainly people between 20 and 40 years old. 
This situation worsened, becoming a major public health 
problem, mostly due to the suspected correlation be-
tween Zika and the microcephaly in newly born children, 
as well as cases of the Guillain-Barre syndrome.
The virus and the vector
Zika is a mosquito-borne viral disease caused by 
the Zika virus (ZIKAV), a flavivirus from the Flaviviridae 
Family. Flaviviruses are RNA viruses that circulate in cycles 
involving vertebrate hosts and insect vectors. It includes 
multiple long known human, animal and zoonotic patho-
gens such as the Dengue virus, the Yellow fever virus, the 
West Nilo virus and the Japanese encephalitis virus.2 The 
Zika virus was first isolated in 1947 from monkeys in the 
Zika forest of Uganda.8
The transmission occurs via mosquito vectors from 
the Aedes genus of the Culicidae Family in a sylvatic cycle 
involving nonhuman primates. Many species of Aedes can 
be involved in the transmission, such as A. africanus, A. 
aegypti, A. albopictus and some other insects like Anoph-
eles and Culex. The potential emergence of arboviruses in 
a region depends on the mosquito vector presence and 
the entry of people with the virus, often in an asymptom-
atic form. Human infection almost always follow the bite 
of an infected tick or mosquito vectors.1,2,5
The virus was identified in urine, breast milk, sali-
va and semen, but the potential transmission by these 
routes was not confirmed.3 In 2008 and 2013, some cases 
probably associating prostatitis, with blood in semen and 
sexual transmission by ZIKAV were related.9,10 Neonatal 
infection is probably transmitted via the placenta or 
during the delivery.7
According to latest studies, the epidermal keratino-
cytes and dendritic immature cells are susceptible to the 
infection by ZIKV. The cutaneous fibroblastes infection 
is associated to the production of viral particles and the 
formation of autophagosomes.7 After the infection, the 
virus invades the human cells and promotes an interac-
tion with the endoplasmatic reticulum like a replication 
platform, inducing a profound remodeling of its archi-
tecture and composition. It includes the activation and 
rearrangement of cellular pathways related to this organ-
elle which are connected with other relevant pathways 
as apoptosis and innate immunity.2 Pioneering studies 
indicate the flaviviral replication complex as a promising 
target for the development of antiviral compounds.11 
Various members of the flavivirus have ability to gain 
entry to the central nervous system - a process known 
as viral neuroinvasiveness - and to infect neural cells - a 
phenomenon known as neurovirulence. Both abilities 
seem to be widely dispersed among various members 
of the Flavivirus genes, which have a global distribution 
range and suggest the existence of potential emergence 
or more neurovirulent dengue strains.12 In a study held 
in the 1970s, the neurotropism of the virus has been 
demonstrated in experimental studies in mices.13
The disease
A substantial proportion of ZIKAV infections are 
subclinical, and even the vast majority of patients are 
asymptomatic. There are no pathognomonic signs. The 
viruses generally cause a self-limiting illness, which most 
common symptoms are the same reported to other 
arboviral infections like dengue and chikungunya: low 
grade fever, maculopapular rash, headache, non purulent 
conjunctival suffusion, myalgia and joint pains.4,7 These 
symptoms appear after an incubation period lasting 
about four days. Until recently the disease was known 
as not causing serious complications, rarely leading to 
hospitalization or death. Rare cough and gastrointestinal 
disorders like vomiting may occur. When compared to 
other arboviruses - such as dengue fever, Zika causes 
more rash and conjunctival hyperemia, and less labora-
torial changes. Although the joint pain could persist for 
a month, other symptoms may disappear after three to 
seven days of its beginning.3
The laboratory alterations are mild and similar to 
those found in other viruses. They are leucopenia, throm-
bocytopenia, elevation of serum lactic dehydrogenase 
and inflammatory markers as C-reactive protein, fibrin-
ogen and ferritin. The specific laboratory diagnosis is 
based on detection of viral RNA from clinical specimens. 
The viral isolation is only possible during the first four to 
R Epidemiol Control Infec, Santa Cruz do Sul, 6(1):37-40, 2016. [ISSN 2238-3360]
Please cite this article in press as: CIPRIANO, Rosangela. A report about Zika virus in Brazil. Revista de Epidemiologia e Controle de Infecção, Santa Cruz do Sul, 
v. 6, n. 1, jan. 2016. ISSN 2238-3360. Disponível em: <http://online.unisc.br/seer/index.php/epidemiologia/article/view/6959>. Acesso em: 18 abr. 2016. doi: http://
dx.doi.org/10.17058/reci.v6i1.6959.
Páginas 03 de 04
não para fins de citação
in several northeastern states with the record of previous 
rash illness, raising the hypothesis of possible association 
with ZIKAV infection.1,7
During the current outbreak in Brazil, the authorities 
recognized the relationship between the Zika virus and 
the occurrence of microcephaly outbreaks and deaths.19 
3530 suspected cases of microcephaly identified in 724 
municipalities of twenty-one states were reported in 
Brazil until January 2016.18 The state of Pernambuco, the 
first one to identify the rise of microcephaly, has held the 
larger number of cases.19 This fact is unpublished in the 
world medical literature and began a series of discussions 
among experts to identify causes and define diagnosis 
criteria. It was recorded an alteration in the pattern of oc-
currence of microcephaly with clear excess in the number 
of cases in various parts of the northeast. The patterns 
of suspected cases distribution of post infectious micro-
cephaly presented dispersion characteristics. The first 
three months of pregnancy of women with microcephalic 
children correspond to a higher virus circulation period in 
the Northeast region in Brazil. More than 60 women that 
referred rash during the pregnancy had affected babies 
without familiar genetic diseases. The Zika virus RNA was 
identified in the amniotic fluid of two pregnant women 
whose fetuses had microcephaly. Newly born children 
that had had the diagnosis of microcephaly during the 
pregnancy with positive results to Zika virus who died five 
minutes after birth were also identified. It is known that 
congenital malformations have complex and multifacto-
rial etiology, but the current evidences strongly indicate 
the relationship between Zika virus and microcephaly.20 
From these observations, the health authorities 
have drawn protocols standardizing care, surveillance, 
diagnostic criteria both clinical and laboratorial and rou-
tine care to pregnant women with probable Zika virus 
infection. It also includes routine investigations for fetus 
with central nervous system alterations probably related 
to Zika virus during the pregnancy and spontaneous 
seven days from the onset of the symptoms, when the 
viruses are circulating. After this period, the production 
of IgM antibodies begin followed by the production of 
IgG antibodies two weeks later.14,15
There is no specific treatment for ZIKAV infection. 
For symptomatic patients it is recommended the use of 
acetaminophen to control the fever and pain. Anti hista-
mines can help to relieve itching. Anti-inflammatory and 
acetylsalicylic acid should not be used, as well as in all 
the infections caused by flaviviruses, due to the increased 
risk of bleeding.3
The current outbreak in Brazil
Neurological and auto-immune complications were 
reported in the outbreak occurred in the French Polynesia 
in 2013.16 On 24 November 2015, the health authorities of 
the French Polynesia reported an unusual increase of at 
least 17 cases of central nervous system malformations 
in fetuses and infants during 2014-2015, coinciding with 
the Zika outbreaks on the island, including fetal cerebral 
malformations or brain lesions, brainstem dysfunction 
and absence of swallowing. None of the pregnant wom-
en described clinical signs of ZIKV infections, but the 
four of them tested were found positive for flavivirus, 
suggesting a possible asymptomatic ZIKV infection. It 
was hypothesized that ZIKV infection may be associated 
with these abnormalities if mothers are infected during 
the first or second trimester of pregnancy.16
In Brazil, the introduction of the Zika virus was sup-
posed to be started in the second half of 2014.3 And it was 
confirmed in May 2015. Its spread was laboratory con-
firmed in 18 states, distributed in the five regions of the 
country, featuring an outbreak.17 The outbreak peaked in 
May with overall attack rate 5.5 cases/10,000 inhabitants. 
In January 2016 there are laboratorial confirmed cases 
in 20 states, involving almost all the country.18 Between 
January and July 2015, 121 cases of neurological mani-
festations of the Guillain-Barré syndrome were notified 
Figure 1. States in Brazil with laboratorial confirmation of ZIKAV infection. 2015-2016. 
From: National Program of Dengue Control (CGPNCD/DEVIT/SVS)18
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abortion and stillbirth or newborn presenting microceph-
aly, probably related to Zika virus infection during the 
pregnancy. This protocol also describes the occurrence 
of the neurological syndrome related to ZIKAV, causing 
Guillain-Barré or acute disseminated encephalomyelitis. 
The objective of this protocol is to optimize the care of 
affected persons and the prevention of new cases, in an 
attempt to minimize damage and control this outbreak 
which represents a serious public health problem in Brazil.20
The prevention is another challenge in this disease. 
There is no vacccine to prevent ZIKAV disease. The most 
importante form to prevent is by avoiding mosquito bites. 
It is recommended the use of repellents, the wearing of 
long-sleeved shirts and long pants and air conditioning 
or window/door screens to keep mosquitoes outside. 
Although mosquitoes may bite at any time of day, peak 
biting activity for the vector is during daylight hours. It 
is also very important to take care of the environment 
to prevent the proliferation of mosquitoes by emptying 
standing water from containers such as flowerpots or 
buckets.21 It is really a new moment to an old virus.
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